[1]
“Retrospective analysis of suspected adverse drug reactions reported in tertiary care hospital”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 4, pp. 414–426, Jul. 2022, doi: 10.25004/IJPSDR.2022.140408.